Literature DB >> 11527874

Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis.

J A Fox-Rushby1, K Hanson.   

Abstract

Disability adjusted life years (DALYs) are the sum of the present value of future years of lifetime lost through premature mortality, and the present value of years of future lifetime adjusted for the average severity (frequency and intensity) of any mental or physical disability caused by a disease or injury. They have been used as an outcome indicator in micro economic evaluations as well as sectoral prioritization exercises using league tables of cost-effectiveness. However, many of the current analyses are not comparable or transferable because either the assumptions used differ or are unclear, and because results are not presented in a way that allows researchers or policy-makers to re-calculate and re-interpret findings for use in an alternative context. However, at times there have also been miscalculations. This may happen either because evaluators disagree with the assumptions behind DALYs or because the methods of calculation have not been set out clearly. This paper shows how to calculate DALYs for cost-effectiveness analysis using a worked example. It also shows the impact of changing the age weighting and discount rates on estimates of cost-effectiveness, and suggests a set of minimum reporting criteria for using DALYs in cost-effectiveness analysis. Finally, readers are introduced briefly to a selected literature arguing for and against the use of DALYs.

Entities:  

Mesh:

Year:  2001        PMID: 11527874     DOI: 10.1093/heapol/16.3.326

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  121 in total

1.  Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial.

Authors:  Tazeen H Jafar; Muhammad Islam; Rasool Bux; Neil Poulter; Juanita Hatcher; Nish Chaturvedi; Shah Ebrahim; Peter Cosgrove
Journal:  Circulation       Date:  2011-09-19       Impact factor: 29.690

2.  Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.

Authors:  S Kapoor; A Gupta; M Shah
Journal:  Int J Tuberc Lung Dis       Date:  2016-01       Impact factor: 2.373

3.  Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.

Authors:  J Cornuz; A Gilbert; C Pinget; P McDonald; K Slama; E Salto; F Paccaud
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

4.  Public health and policy issues of hernia surgery in Africa.

Authors:  Andrew N Kingsnorth; Michael G Clarke; Samuel D Shillcutt
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

5.  A square peg in a round hole? Challenges with DALY-based "burden of disease" calculations in surgery and a call for alternative metrics.

Authors:  Richard Gosselin; Doruk Ozgediz; Dan Poenaru
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

6.  A methodological guide to performing a cost-utility study comparing surgical techniques.

Authors:  Achilleas Thoma; Ted Haines; Karen Veltri; Charlie H Goldsmith; Bernie J O'Brien; Caroline Quartly
Journal:  Can J Plast Surg       Date:  2004

7.  The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

Authors:  Lesong Conteh; Elisa Sicuri; Fatuma Manzi; Guy Hutton; Benson Obonyo; Fabrizio Tediosi; Prosper Biao; Paul Masika; Fred Matovu; Peter Otieno; Roly D Gosling; Mary Hamel; Frank O Odhiambo; Martin P Grobusch; Peter G Kremsner; Daniel Chandramohan; John J Aponte; Andrea Egan; David Schellenberg; Eusebio Macete; Laurence Slutsker; Robert D Newman; Pedro Alonso; Clara Menéndez; Marcel Tanner
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

8.  Pulmonary impairment after tuberculosis and its contribution to TB burden.

Authors:  Jotam G Pasipanodya; Scott Jn McNabb; Peter Hilsenrath; Sejong Bae; Kristine Lykens; Edgar Vecino; Guadalupe Munguia; Thaddeus L Miller; Gerry Drewyer; Stephen E Weis
Journal:  BMC Public Health       Date:  2010-05-19       Impact factor: 3.295

Review 9.  Dealing with uncertainties in environmental burden of disease assessment.

Authors:  Anne B Knol; Arthur C Petersen; Jeroen P van der Sluijs; Erik Lebret
Journal:  Environ Health       Date:  2009-04-28       Impact factor: 5.984

10.  Determining a cost effective intervention response to HIV/AIDS in Peru.

Authors:  Robert W Aldridge; David Iglesias; Carlos F Cáceres; J Jaime Miranda
Journal:  BMC Public Health       Date:  2009-09-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.